Official reprint from UpToDate
©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
Medline ® Abstract for Reference 67
of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'
Bevacizumab plus irinotecan in recurrent glioblastoma.
J Clin Oncol. 2008;26(6):1012.